Regenxbio Inc.

05/14/2021 | Press release | Distributed by Public on 05/14/2021 05:09

REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell[...]